Passage Bio Inc (PASG)
1.31
-0.03
(-2.24%)
USD |
NASDAQ |
May 03, 16:00
1.35
+0.04
(+3.05%)
After-Hours: 20:00
Passage Bio Shareholders Equity (Quarterly): 111.28M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 111.28M |
| September 30, 2023 | 126.28M |
| June 30, 2023 | 150.41M |
| March 31, 2023 | 170.35M |
| December 31, 2022 | 201.37M |
| September 30, 2022 | 224.40M |
| June 30, 2022 | 248.05M |
| March 31, 2022 | 281.31M |
| December 31, 2021 | 318.66M |
| Date | Value |
|---|---|
| September 30, 2021 | 362.23M |
| June 30, 2021 | 402.27M |
| March 31, 2021 | 441.50M |
| December 31, 2020 | 304.71M |
| September 30, 2020 | 338.90M |
| June 30, 2020 | 363.40M |
| March 31, 2020 | 386.67M |
| December 31, 2019 | -56.25M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-56.25M
Minimum
Dec 2019
441.50M
Maximum
Mar 2021
257.38M
Average
281.31M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 150.54M |
| Total Liabilities (Quarterly) | 39.26M |